(Q39612017)

13 September 2017

Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma (English)

1 reference

13 September 2017

9

Herbert Rübben

1 reference

13 September 2017

Hagen S Bachmann

1

1 reference

13 September 2017

Lukas C Heukamp

2

1 reference

13 September 2017

Klaus J Schmitz

3

1 reference

13 September 2017

Caroline F Hilburn

4

1 reference

13 September 2017

Philip Kahl

5

1 reference

13 September 2017

Reinhard Buettner

6

1 reference

13 September 2017

Holger Nückel

7

1 reference

13 September 2017

Andreas Eisenhardt

8

1 reference

13 September 2017

Kurt Werner Schmid

10

1 reference

13 September 2017

Winfried Siffert

11

1 reference

13 September 2017

Angelika Eggert

12

1 reference

13 September 2017

Alexander Schramm

13

1 reference

13 September 2017

Johannes H Schulte

14

1 reference

13 September 2017

language of work or name

English

0 references

publication date

25 March 2011

1 reference

International Journal of Cancer

13 September 2017

1 reference

13 September 2017

129

1 reference

13 September 2017

10

1 reference

13 September 2017

2390-2399

1 reference

A history of prostate cancer treatment

13 September 2017

1 reference

International trends and patterns of prostate cancer incidence and mortality

21 January 2018

1 reference

Prostate cancer screening (United States).

21 January 2018

1 reference

Clinical practice. Localized prostate cancer

21 January 2018

1 reference

Prognostic significance of histologic grading in patients with prostate carcinoma who are assessed by the Gleason and World Health Organization grading systems in needle biopsies obtained prior to radiotherapy.

21 January 2018

1 reference

Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer

21 January 2018

1 reference

p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate

21 January 2018

1 reference

High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy

21 January 2018

1 reference

Mechanisms of Disease: biomarkers and molecular targets from microarray gene expression studies in prostate cancer

21 January 2018

1 reference

Clinical utility of microarray-derived genetic signatures in predicting outcomes in prostate cancer

21 January 2018

1 reference

The Bcl2 family: regulators of the cellular life-or-death switch

21 January 2018

1 reference

BCL2 family in DNA damage and cell cycle control

21 January 2018

1 reference

The BCL2-family of protein ligands as cancer drugs: the next generation of therapeutics.

21 January 2018

1 reference

Knock-down of Bcl-2 by antisense oligodeoxynucleotides induces radiosensitization and inhibition of angiogenesis in human PC-3 prostate tumor xenografts.

21 January 2018

1 reference

HA14-1, a small molecule inhibitor of Bcl-2, bypasses chemoresistance in leukaemia cells

21 January 2018

1 reference

A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancer

21 January 2018

1 reference

A negative regulatory element in the bcl-2 5'-untranslated region inhibits expression from an upstream promoter

21 January 2018

1 reference

Identification of variants in cyclin D1 ( CCND1) and B-Cell CLL/lymphoma 2 ( BCL2).

21 January 2018

1 reference

The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma.

21 January 2018

1 reference

Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia

21 January 2018

1 reference

Bcl2 -938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy.

21 January 2018

1 reference

Germline BCL-2 sequence variants and inherited predisposition to prostate cancer.

21 January 2018

1 reference

BCL2 expression in chronic lymphocytic leukemia: lack of association with the BCL2 938A>C promoter single nucleotide polymorphism

21 January 2018

1 reference

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

21 January 2018

1 reference

Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.25904

1 reference

release_cqnoya4pundv5absozryq4dhce

13 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cqnoya4pundv5absozryq4dhce

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference